Keyphrases
People Living with HIV (PLHIV)
100%
Antiretroviral Therapy
56%
Integrase Strand Transfer Inhibitor (INSTI)
55%
B Cell Response
38%
Germinal Center Reaction
36%
MRNA Vaccine
34%
Memory B Cells
30%
AIDS/HIV
25%
Germinal Center
25%
Bone Marrow Plasma Cells
24%
Lymph Node
23%
Germinal Center B Cells
20%
COVID-19
19%
Randomized Clinical Trial
19%
Somatic Depressive Symptoms
19%
Abatacept
19%
Management Strategy
19%
Temozolomide
19%
Obesity
19%
COVID-19 Pneumonia
19%
Infliximab
19%
Long Peripheral Catheter
19%
Incident Diabetes Mellitus
19%
Cenicriviroc
19%
Cavernous Sinus Thrombosis
19%
MSSA Bacteremia
19%
Antibiotic Choices
19%
Influenza A
19%
Retrospective Review
19%
Major Complications
19%
Intracranial Thrombosis
19%
Depressive Symptoms
19%
SARS-CoV-2 Vaccination
19%
Intensive Care Unit
19%
Antiretroviral
19%
SARS-CoV-2 Omicron
19%
United States
19%
Cardiovascular Risk
19%
Adverse Cardiac Events
19%
Risk Difference
19%
SARS-CoV-2 Spike Protein
18%
Antiretroviral Therapy Regimens
18%
Monoclonal Antibody
17%
Placebo
16%
Somatic Hypermutation
15%
SARS-CoV-2 mRNA Vaccine
13%
Protease Inhibitors
12%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
12%
Chronic Depression
11%
Two-dose
11%
Medicine and Dentistry
Human Immunodeficiency Virus
77%
Integrase
38%
Germinal Center
29%
Intensive Care Unit
29%
Antibiotics
29%
B Cell
24%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
COVID-19
21%
Antiretroviral Therapy
21%
Omicron Coronavirus Variant
19%
Influenza A
19%
Methicillin Susceptible Staphylococcus Aureus
19%
Catheter Infection
19%
Cavernous Sinus Thrombosis
19%
COVID-19 Vaccination
19%
Deep Vein Thrombosis
19%
Decision Making
19%
Lymph Node
19%
Occlusive Cerebrovascular Disease
19%
Diabetes Mellitus
19%
Cenicriviroc
19%
Retrospective Study
19%
Infliximab
19%
Placebo
19%
Abatacept
19%
Randomized Clinical Trial
19%
Bloodstream Infection
19%
mRNA Vaccine
14%
Hyperglycemia
11%
Gaze Paralysis
9%
Thrombophlebitis
9%
Staphylococcal Bacteremia
9%
Sepsis
9%
Staphylococcus Aureus
9%
Panton Valentine Leukocidin
9%
Internal Jugular Vein
9%
Thrombosis
9%
Antiinfective Agent
9%
Clinician
9%
Diseases
9%
Hazard Ratio
8%
Odds Ratio
8%
Infection
7%
Memory B Cell
7%
Epitope
7%